Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study.
Int J Infect Dis
; 107: 188-194, 2021 Jun.
Article
em En
| MEDLINE
| ID: mdl-33862208
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Receptores de Ativador de Plasminogênio Tipo Uroquinase
/
SARS-CoV-2
/
COVID-19
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Int J Infect Dis
Ano de publicação:
2021
Tipo de documento:
Article